Change in alcohol and tobacco consumption after a diagnosis of head and neck cancer: Findings from Head and Neck 5000

Head & Neck
Chris M PenfoldAndrew R Ness

Abstract

Tobacco and alcohol consumption are risk factors for developing head and neck cancer, and continuation postdiagnosis can adversely affect prognosis. We explored changes to these behaviors after a head and neck cancer diagnosis. Demographic and clinical data were collected from 973 people newly diagnosed with oral cavity, oropharyngeal, or laryngeal cancer. Tobacco and alcohol consumption were additionally collected 4 and 12 months later. The prevalence of high alcohol consumption reduced from 54.3% at diagnosis to 41.4% at 12 months, and smoking reduced from 21.0% to 11.7%. Changes in behavior were dynamic, for example, 44% of smokers at 12 months were not smoking at diagnosis or 4 months. Several factors were associated with alcohol consumption, whereas only tumor site and comorbidities were associated with smoking. A diagnosis of head and neck cancer can result in important changes in alcohol consumption and smoking prevalence. However, these changes are dynamic in the first year after diagnosis.

References

May 1, 1976·Journal of the Experimental Analysis of Behavior·R R GriffithsI Liebson
Jul 1, 1992·Clinical Oncology : a Journal of the Royal College of Radiologists·C Des RochersM I Saunders
Jul 1, 1995·Addictive Behaviors·E P WhitlockD Abbey
Jan 21, 1993·The New England Journal of Medicine·G P BrowmanM N Levine
Apr 17, 1996·Journal of the National Cancer Institute·F W DeleyiannisS Davis
Jan 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert A SchnollPaul F Engstrom
May 6, 2003·Health Education Research·C M McBrideI M Lipkus
May 27, 2004·JAMA : the Journal of the American Medical Association·Jay F PiccirilloEdward L Spitznagel
Nov 23, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Sonia A DuffyJeffrey E Terrell
Aug 10, 2007·Head & Neck·Sonia A DuffyJeffrey E Terrell
Nov 28, 2008·International Journal of Radiation Oncology, Biology, Physics·André FortinEric Vigneault
Feb 5, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Mia HashibePaolo Boffetta
Feb 28, 2009·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Sarah Connor GorberMark Tremblay
Jun 26, 2009·Journal of Cranio-maxillo-facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery·Bernardo BianchiEnrico Sesenna
Nov 11, 2009·Journal of Cancer Survivorship : Research and Practice·Nikki A HawkinsKevin D Stein
Jun 10, 2010·The New England Journal of Medicine·K Kian AngMaura L Gillison
Sep 22, 2010·BMJ : British Medical Journal·H MehannaC Nutting
Sep 30, 2010·BMJ : British Medical Journal·H MehannaV Paleri
Mar 27, 2012·The British Journal of Oral & Maxillofacial Surgery·Caroline DruganSteven Thomas
Oct 2, 2012·International Journal of Cancer. Journal International Du Cancer·Luisa ZuccoloGeorge Davey Smith
Dec 7, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Nathalie Druesne-PecolloPaule Latino-Martel
Sep 27, 2014·Cancers·Francesca Romana FioriniOreste Gallo
Feb 12, 2015·The New England Journal of Medicine·Brian D CarterEric J Jacobs
Aug 19, 2015·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jessica L BurrisJamie S Ostroff
Oct 6, 2015·Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·A R NessUNKNOWN Head and Neck 5000 Study Team

❮ Previous
Next ❯

Citations

Jul 25, 2019·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Yu-Hsuan LinYi-Ting Yen
Feb 18, 2020·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·S N RogersA R Ness
Mar 19, 2021·International Heart Journal·Taro TakeuchiUNKNOWN Osaka Acute Coronary Insufficiency Study (OACIS) Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.